In a finding that could put an end to the use of medication in the treatment of social anxiety disorder, researchers have shown that structured talk therapy or cognitive alone has the potential to cure social phobia.
In treating patients with social anxiety disorder, cognitive therapy on its own has a much better effect over the long term than just drugs or a combination of the two, said the study.
"This is the most effective treatment ever for this patient group. Treatment of mental illness often isn't as effective as treating a bone fracture, but here we've shown that treatment of psychiatric disorders can be equally effective," said lead researcher Hans Nordahl, Professor at the Norwegian University of Science and Technology (NTNU).
Social anxiety is not a diagnosis, but a symptom that a lot of people struggle with. For example, talking or being funny on command in front of a large audience can trigger this symptom.
Until now, a combination of cognitive therapy and medication was thought to be the most effective treatment for these patients.
In this study involving over 100 patients -- published in the journal Psychotherapy and Psychosomatics -- nearly 85 per cent of the study participants significantly improved or became completely healthy using only cognitive therapy.
"A lot of doctors and hospitals combine medications - like the famous "happy pill" - with talk therapy when they treat this patient group. It works well in patients with depressive disorders, but it actually has the opposite effect in individuals with social anxiety disorders. Not many health care professionals are aware of this," Nordahl noted.
"Happy pills," like selective serotonin reuptake inhibitors (SSRIs), may have strong physical side effects.
The researchers noted that when patients have been on medications for some time and want to reduce them, the bodily feelings associated with social phobia, like shivering, flushing and dizziness in social situations tend to return.
Patients often end up in a state of acute social anxiety again.
"The medication camouflages a very important patient discovery: that by learning effective techniques, they have the ability to handle their anxiety themselves," Nordahl said.
--IANS
gb/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
